tiprankstipranks
Trending News
More News >
Kalaris Therapeutics (KLRS)
NASDAQ:KLRS
US Market

Compare Kalaris Therapeutics (KLRS) vs. Competitors

Compare
370 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Kalaris Therapeutics
$9.20
$148.63M
-1.20
-5.63%
3 Buy
1 Hold
0 Sell
Strong Buy
Coherus Biosciences
$2.33
$261.08M
60.00%
4 Buy
0 Hold
0 Sell
Strong Buy
Nektar Therapeutics
$37.33
$759.35M
-4.70
192.58%
6 Buy
1 Hold
1 Sell
Moderate Buy
Cellectis SA
$3.99
$278.64M
-11.37
139.87%
2 Buy
2 Hold
0 Sell
Moderate Buy
Seres Therapeutics
$15.63
$134.97M
24.58
-12.89%
2 Buy
0 Hold
0 Sell
Moderate Buy
Kodiak Sciences
$25.43
$1.39B
-5.53
234.85%
4 Buy
2 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
KLRS
Kalaris Therapeutics
8.88
-0.54
-5.73%
CHRS
Coherus Biosciences
2.16
0.98
83.05%
NKTR
Nektar Therapeutics
37.33
24.92
200.81%
CLLS
Cellectis SA
3.79
2.18
135.40%
MCRB
Seres Therapeutics
14.92
-1.98
-11.72%
KOD
Kodiak Sciences
22.77
16.37
255.78%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts